Deregulation of apoptotic volume decrease and ionic movements in multidrug-resistant tumor cells: Role of chloride channels

American Journal of Physiology - Cell Physiology

Volumn 298, Issue 1, 2010, Pages

  Poulsen, K A ^a   Andersen, E C ^a   Hansen, C F ^a   Klausen, T K ^a   Hougaard, C ^b   Lambert, I H ^a   Hoffmann, E K ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b NEUROSEARCH A S   (Denmark)

Author keywords

Caspase 3; Cell volume; Cisplatin; Volume regulated anion channel

Indexed keywords

AMINO ACID; ANION CHANNEL; ANTHRACYCLINE; CASPASE 3; CHLORIDE CHANNEL; CHLORIDE CHANNEL BLOCKING AGENT; CHLORIDE ION; CISPLATIN; DAUNORUBICIN; NINHYDRIN; NS 3728; POTASSIUM ION; SODIUM CHLORIDE; SODIUM ION; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL CULTURE; CELL LINE; CELL LOSS; CELL MEMBRANE PERMEABILITY; CELL VIABILITY; CELL VOLUME; CHLORIDE TRANSPORT; CONTROLLED STUDY; CYTOTOXICITY; DEREGULATION; ENZYME ACTIVITY; GENE EXPRESSION; ION CURRENT; KINETICS; MOLECULAR DYNAMICS; MULTIDRUG RESISTANCE; NONHUMAN; PHASE TRANSITION; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; REGULATORY MECHANISM; TUMOR CELL; WATER LOSS; WILD TYPE;

ANIMALS; APOPTOSIS; CARRIER PROTEINS; CELL CYCLE; CELL SIZE; CHLORIDE CHANNELS; CISPLATIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; HOMEOSTASIS; HUMANS; NEOPLASMS; P-GLYCOPROTEIN;

EID: 73549125435     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00654.2008     Document Type: Article

References (50)

1. Beketic-Oreskovic L, Osmak M. Modulation of resistance to cisplatin by amphotericin B and aphidicolin in human larynx carcinoma cells. Cancer Chemother Pharmacol 35: 327-333, 1995.
2. Bortner CD, Cidlowski JA. Cell shrinkage and monovalent cation fluxes: role in apoptosis. Arch Biochem Biophys 462: 176-188, 2007.
3. Bortner CD, Sifre MI, Cidlowski JA. Cationic gradient reversal and cytoskeleton-independent volume regulatory pathways define an early stage of apoptosis. J Biol Chem 283: 7219-7229, 2008.
4. D'Anglemont dT, Berdeaux A, Souktani R, Henry P, Ghaleh B. The volume-sensitive chloride channel inhibitors prevent both contractile dysfunction and apoptosis induced by doxorubicin through PI3kinase, Akt and Erk 1/2. Eur J Heart Fail 10: 39-46, 2008.
5. D'Anglemont DT, Souktani R, Henry P, Ghaleh B, Berdeaux A. Volume-sensitive chloride channels (I) mediate doxorubicin-induced apoptosis through apoptotic volume decrease in cardiomyocytes. Fundam Clin Pharmacol 18: 531-538, 2004.
6. Dano K. Active outward transport of daunomycin in resistant Ehrlich ascites tumor cells. Biochim Biophys Acta 323: 466-483, 1973.
7. Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol 35: 495-516, 2007.
8. Ernest NJ, Habela CW, Sontheimer H. Cytoplasmic condensation is both necessary and sufficient to induce apoptotic cell death. J Cell Sci 121: 290-297, 2008.
9. Friis MB, Friborg CR, Schneider L, Nielsen MB, Lambert IH, Christensen ST, Hoffmann EK. Cell shrinkage as a signal to apoptosis in NIH 3T3 fibroblasts. J Physiol 567: 427-443, 2005.
10. Gollapudi S, McDonald T, Gardner P, Kang N, Gupta S. Abnormal chloride conductance in multidrug resistant HL60/AR cells. Cancer Lett 66: 83-89, 1992.
11. Helix N, Strobaek D, Dahl BH, Christophersen P. Inhibition of the endogenous volume-regulated anion channel (VRAC) in HEK293 cells by acidic di-aryl-ureas. J Membr Biol 196: 83-94, 2003.
12. Hengartner MO. The biochemistry of apoptosis. Nature 407: 770-776, 2000.
13. Hoffmann EK, Lambert IH, Pedersen SF. Physiology of cell volume regulation in vertebrates. Physiol Rev 89: 193-277, 2009.
14. - transport pathways in Ehrlich ascites tumor cells. J Membr Biol 91: 227-244, 1986.
15. Hoffmann EK, Simonsen LO, Sjoholm C. Membrane potential, chloride exchange, and chloride conductance in Ehrlich mouse ascites tumour cells. J Physiol 296: 61-84, 1979.
16. Hortelano S, Zeini M, Castrillo A, Alvarez AM, Bosca L. Induction of apoptosis by nitric oxide in macrophages is independent of apoptotic volume decrease. Cell Death Differ 9: 643-650, 2002.
17. + suppresses the activation of apoptosis in lymphocytes. J Biol Chem 272: 30567-30576, 1997.
18. Ikuta K, Takemura K, Sasaki K, Kihara M, Nishimura M, Ueda N, Naito S, Lee E, Shimizu E, Yamauchi A. Expression of multidrug resistance proteins and accumulation of cisplatin in human non-small cell lung cancer cells. Biol Pharm Bull 28: 707-712, 2005.
19. - channel in cisplatin-induced apoptosis in human epidermoid cancer cells. J Membr Biol 205: 139-145, 2005.
20. 2+/calmodulin and protein kinase C dependent pathways. J Membr Biol 131: 161-178, 1993.
21. + channels and volume-regulated anion channels in multidrugresistant small cell lung cancer cells. Cancer Res 53: 4156-4160, 1993.
22. Karki P, Seong C, Kim JE, Hur K, Shin SY, Lee JS, Cho B, Park IS. Intracellular K(+) inhibits apoptosis by suppressing the Apaf-1 apoptosome formation and subsequent downstream pathways but not cytochrome c release. Cell Death Differ 14: 2068-2075, 2007.
23. 2+-activated anion currents in Ehrlich lettre ascites cells. J Cell Physiol 210: 831-842, 2007.
24. Krishna R, Mayer LD. Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs. Eur J Pharm Sci 11: 265-283, 2000.
25. Kunzelmann K, Slotki IN, Klein P, Koslowsky T, Ausiello DA, Greger R, Cabantchik ZI. Effects of P-glycoprotein expression on cyclic AMP and volume-activated ion fluxes and conductances in HT-29 colon adenocarcinoma cells. J Cell Physiol 161: 393-406, 1994.
26. Lang F, Foller M, Lang K, Lang P, Ritter M, Vereninov A, Szabo I, Huber SM, Gulbins E. Cell volume regulatory ion channels in cell proliferation and cell death. Methods Enzymol 428: 209-225, 2007.
27. - channel is involved in cisplatin resistance of cancer cells. J Cell Physiol 211: 513-521, 2007.
28. Liang F, Schulte BA, Qu C, Hu W, Shen Z. Inhibition of the calciumand voltage-dependent big conductance potassium channel ameliorates cisplatin-induced apoptosis in spiral ligament fibrocytes of the cochlea. Neuroscience 135: 263-271, 2005.
29. Litman T, Nielsen D, Skovsgaard T, Zeuthen T, Stein WD. ATPase activity of P-glycoprotein related to emergence of drug resistance in Ehrlich ascites tumor cell lines. Biochim Biophys Acta 1361: 147-158, 1997.
30. Litman T, Pedersen SF, Kramhoft B, Skovsgaard T, Hoffmann EK. pH regulation in sensitive and multidrug resistant Ehrlich ascites tumor cells. Cell Physiol Biochem 8: 138-150, 1998.
31. + exchange during regulatory volume decrease in Ehrlich ascites tumor cells. J Membr Biol 114: 153-157, 1990.
32. Lothstein L, Israel M, Sweatman TW. Anthracycline drug targeting: cytoplasmic versus nuclear-a fork in the road. Drug Resist Updat 4: 169-177, 2001.
33. - currents in MES-SA cells. Am J Physiol Cell Physiol 270: C1029-C1036, 1996.
34. Maeno E, Ishizaki Y, Kanaseki T, Hazama A, Okada Y. Normotonic cell shrinkage because of disordered volume regulation is an early prerequisite to apoptosis. Proc Natl Acad Sci USA 97: 9487-9492, 2000.
35. Maeno E, Takahashi N, Okada Y. Dysfunction of regulatory volume increase is a key component of apoptosis. FEBS Lett 580: 6513-6517, 2006.
36. Marklund L, Andersson B, Behnam-Motlagh P, Sandstrom PE, Henriksson R, Grankvist K. Cellular potassium ion deprivation enhances apoptosis induced by cisplatin. Basic Clin Pharmacol Toxicol 94: 245-251, 2004.
37. Marklund L, Henriksson R, Grankvist K. Cisplatin-induced apoptosis of mesothelioma cells is affected by potassium ion flux modulator amphotericin B and bumetanide. Int J Cancer 93: 577-583, 2001.
38. Morikage T, Ohmori T, Nishio K, Fujiwara Y, Takeda Y, Saijo N. Modulation of cisplatin sensitivity and accumulation by amphotericin B in cisplatin-resistant human lung cancer cell lines. Cancer Res 53: 3302-3307, 1993.
39. Nilius B, Droogmans G. Amazing chloride channels: an overview. Acta Physiol Scand 177: 119-147, 2003.
40. Okada Y, Maeno E, Shimizu T, Manabe K, Mori S, Nabekura T. Dual roles of plasmalemmal chloride channels in induction of cell death. Pflügers Arch 448: 287-295, 2004.
41. +-ATPase please stand up? Acta Physiol (Oxf) 187: 205-215, 2006.
42. 2+-activated anion currents in Ehrlich ascites tumor cells. J Membr Biol 163: 97-110, 1998.
43. - conductance. Cell Death Differ 11: 655-662, 2004.
44. Poulsen KA, Litman T, Eriksen J, Mollerup J, Lambert IH. Downregulation of taurine uptake in multidrug resistant Ehrlich ascites tumor cells. Amino Acids 22: 333-350, 2002.
45. Shimizu T, Lee EL, Ise T, Okada Y. Volume-sensitive Cl(-) channel as a regulator of acquired cisplatin resistance. Anticancer Res 28: 75-83, 2008.
46. Stavrovskaya AA. Cellular mechanisms of multidrug resistance of tumor cells. Biochemistry (Mosc) 65: 95-106, 2000.
47. - channel blockers in mouse cardiomyocytes. Cell Physiol Biochem 15: 263-270, 2005.
48. +] inhibits death-receptor- and chemical-mediated apoptosis prior to caspase activation and cytochrome c release. Biochem J 357: 137-145, 2001.
49. Yurinskaya V, Goryachaya T, Guzhova I, Moshkov A, Rozanov Y, Sakuta G, Shirokova A, Shumilina E, Vassilieva I, Lang F, Vereninov A. Potassium and sodium balance in U937 cells during apoptosis with and without cell shrinkage. Cell Physiol Biochem 16: 155-162, 2005.
50. Zisowsky J, Koegel S, Leyers S, Devarakonda K, Kassack MU, Osmak M, Jaehde U. Relevance of drug uptake and efflux for cisplatin sensitivity of tumor cells. Biochem Pharmacol 73: 298-307, 2007.